Driving CAR-based T-cell therapy to success.

Driving CAR-based T-cell therapy to success.

Item
http://www.wikidata.org/entity/Q37715684
Targeted Therapies in Adult B-Cell MalignanciesCD19-redirected chimeric antigen receptor-modified T cells: a promising immunotherapy for children and adults with B-cell acute lymphoblastic leukemia (ALL)Immunological and Translational Aspects of NK Cell-Based Antitumor ImmunotherapiesUtilizing chimeric antigen receptors to direct natural killer cell activityThe human application of gene therapy to re-program T-cell specificity using chimeric antigen receptorsWhat the shark immune system can and cannot provide for the expanding design landscape of immunotherapy.Manufacturing genetically modified T cells for clinical trials.T cells expressing an anti-B-cell maturation antigen chimeric antigen receptor cause remissions of multiple myeloma.Chimeric Antigen Receptor T-Cells for the Treatment of B-Cell Acute Lymphoblastic Leukemia.Genetically enhanced T lymphocytes and the intensive care unit.
P2860

Driving CAR-based T-cell therapy to success.

Item
http://www.wikidata.org/entity/Q37715684
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Driving CAR-based T-cell therapy to success.
@en
Driving CAR-based T-cell therapy to success.
@nl
type
label
Driving CAR-based T-cell therapy to success.
@en
Driving CAR-based T-cell therapy to success.
@nl
prefLabel
Driving CAR-based T-cell therapy to success.
@en
Driving CAR-based T-cell therapy to success.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P5875
P698
P932
P356
P1433
P1476
Driving CAR-based T-cell therapy to success.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P5875
P698
P932